| [1] |
.
Advances in immunogenetic mechanisms of drug-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 0-0.
|
| [2] |
ZENG Xiangchang1, 2, 3, 4, 5, 7, RAO Tai1, 3, 4, 5, CHEN Lulu2, LI Chaopeng2, ZENG Guirong6, CHEN Jun7, OUYANG Dongsheng1, 2, 3, 4, 5.
Advances in immunogenetic mechanisms of drug-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 1133-1146.
|
| [3] |
LI Hui, HU Hengzhao, YU Tingting, HU Huixian, WANG Jiale, WU Jing, HAO Wei.
Plumbagin ameliorates pulmonary fibrosis by modulating TGF-β1/Smad2 and Nrf2/NOX4 pathways
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 61-69.
|
| [4] |
YU Dan, LIU Zongtao, YAN Xiaohong, CHENG Jing, LI lin.
Effects of osthole on renal oxidative stress injury in aged spontaneously hypertensive rats by regulating PI3K/Akt/mTOR signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 277-282.
|
| [5] |
WEI Feng, HE Yang, FAN Zhiqiang, LIU Shikun, OUYANG Linqi.
Inhibitory effect of flufenidone on TGF-β1/Smads pathway in hepatocytes of rats with diethylnitrosamine (DEN)-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 739-746.
|
| [6] |
JIN Yiyi, ZHOU Keting, YANG Chengcheng, XU Ping, ZHU Suyan.
Osthole attenuates diabetes-induced renal injury by regulating NF-κB and p38/MAPK pathway mediated inflammatory responses
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 622-631.
|
| [7] |
XING Bomin, GUO Na, NING Haihui, DING Xinyun, MA Yuqing.
Effects of Rho kinase inhibitors on septic liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 544-550.
|
| [8] |
NIU Pilian, FAN Yongxin, LU Furui, ZHOU Xuezhang, BAI Mingsheng.
Effects of liquorice extract on cardiac fibroblasts fibrosis induced by TGF-β1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 129-135.
|
| [9] |
LIU Wenjing, WU Zhitao, PAN Guoyu.
Early dectection and prediction hepatotoxic risk in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 923-930.
|
| [10] |
SONG Ruzheng, PENG Ying, WANG Guangji, SUN Jianguo.
Commonly used quantitative proteomics research techniques and their application in the study of pathogenesis of liver-derived diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 570-578.
|
| [11] |
GAO Yan, LI Juntong, WU Qinglin, LI Lin, ZHANG Lan.
Tetrahydroxy stilbene glycoside protects mice from acetaminophen-induced liver injury: study based on metabonomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 161-166.
|
| [12] |
LIU Peng, ZHAO Hailing, SHEN Zhengri, WANG Chen, WANG Yun, QIU Xinping, LI Ping.
Tangshen formula promotes cellular cholesterol efflux in HG-induced mTECs by suppression of TGF-β1/Smad3 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 1-9.
|
| [13] |
XU Lina, LI Yue, PENG Jinyong.
microRNA and drug-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 803-809.
|
| [14] |
WANG Qian, SU Huizong, LI Yue, TAN Bo, YAN Dongming, JIN Jingyi, QIU Furong.
Hepatoprotective effects of Yinchenzhufu decoction on intrahepatic cholestasis liver injury in mice induced by ANIT via suppressing TLR4/NF-κB pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 601-609.
|
| [15] |
XIE Jiali, LI Jun.
Endoplasmic reticulum stress-induced apoptosis up-regulation of DR5 via a CHOP-dependent mechanism in HSC-T6 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(2): 159-166.
|